http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.gif 144 PEMBROKE, Bermuda, November 5 /PRNewswire/ -- Allied World Assurance Company Holdings, Ltd (NYSE: AWH) today reported net income of $200.6 million, or $3.83 per diluted share, for the third quarter... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3939 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3939 Thu, 05 Nov 2009 23:19:00 +0000 DUBLIN, October 30 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company, announces results for the three months to September 30, 2009. http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3901 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3901 Fri, 30 Oct 2009 13:08:00 +0000 MCKINNEY, Texas, October 28 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) reported today that for the quarter ended September 30, 2009, net income was US$1.22 per share compared with US$.72 per... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3887 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3887 Wed, 28 Oct 2009 20:00:00 +0000 MCKINNEY, Texas, October 27 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) will release Third Quarter 2009 earnings after the market closes on Wednesday, October 28, 2009. In conjunction with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3876 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3876 Tue, 27 Oct 2009 11:00:00 +0000 RALEIGH, North Carolina, October 26 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces that its Vice President of Clinical Affairs for Early Development... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3869 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3869 Mon, 26 Oct 2009 12:30:00 +0000 MCKINNEY, Texas, October 26 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) will release Third Quarter 2009 earnings after the market closes on Wednesday, October 28, 2009. In conjunction with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3866 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3866 Mon, 26 Oct 2009 11:00:00 +0000 CHARENTON-LE-PONT, France, October 22 /PRNewswire/ -- Essilor International, the world leader in ophthalmic optics, today announced its consolidated revenue for the nine months ended September 30,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3846 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3846 Thu, 22 Oct 2009 06:25:00 +0000 CALGARY, Canada, September 25 /PRNewswire/ -- Resverlogix Corp. (TSX:RVX) announced today that it will host a live teleconference and webcast on Tuesday, September 29, 2009 at 1:00 pm Eastern/11:00... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3721 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3721 Fri, 25 Sep 2009 18:21:00 +0000 THOUSAND OAKS, California, September 22 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced detailed results from the Phase 3 '181' trial evaluating Vectibix(R) (panitumumab) in combination with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3684 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3684 Tue, 22 Sep 2009 08:28:00 +0000 THOUSAND OAKS, California, September 21 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced detailed results from a Phase 3 trial evaluating denosumab administered subcutaneously versus... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3675 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3675 Mon, 21 Sep 2009 10:53:00 +0000 THOUSAND OAKS, California, September 16 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced it will present detailed data from four Phase 3 studies as well as other data at the ECCO 15 - ESMO 34... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3657 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3657 Wed, 16 Sep 2009 14:56:00 +0000 OSLO, September 3 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3572 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3572 Thu, 03 Sep 2009 07:00:00 +0000 LONDON, August 25 /PRNewswire/ -- Chronic wounds cause immense suffering, healthcare expenditure, and disability for millions of patients - and make the wound care market a billion dollar market.... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3511 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3511 Tue, 25 Aug 2009 12:19:00 +0000 AMSTERDAM, August 13 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today reported its results for the first half year of 2009. http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3465 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3465 Thu, 13 Aug 2009 06:00:00 +0000 LONDON, August 5 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company, announces results for the three months to June 30, 2009. Q2 2009 Financial... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3443 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3443 Wed, 05 Aug 2009 13:26:00 +0000 ABU DHABI, UAE, August 3 /PRNewswire/ -- The region's first and only summit on military medicine, Defence Healthcare 2009 will be held from 22nd - 25th November 2009 at the Hilton Hotel in Abu... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3429 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3429 Mon, 03 Aug 2009 07:00:00 +0000 LONDON, July 28 /PRNewswire/ -- In order to increase productivity, healthcare providers have started to integrate many IT-based ancillary systems such as EMR, HIS and PACS. So far, this has purely... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3414 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3414 Tue, 28 Jul 2009 10:00:00 +0000 CHARENTON-LE-PONT, France, July 17 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3386 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3386 Fri, 17 Jul 2009 06:37:00 +0000 PEMBROKE, Bermuda, July 8 /PRNewswire/ -- Allied World Assurance Company Holdings, Ltd (NYSE: AWH) today announced that it will release its financial results for the second quarter ended June 30,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3345 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3345 Wed, 08 Jul 2009 14:33:00 +0000 NEW BRUNSWICK, New Jersey and DUBLIN, July 2 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) and Elan Corporation plc (NYSE: ELN) today announced a definitive agreement whereby Johnson &... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3321 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3321 Thu, 02 Jul 2009 12:51:00 +0000 NEW ORLEANS, June 5 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3166 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3166 Fri, 05 Jun 2009 09:30:00 +0000 LONDON, May 27 /PRNewswire/ -- The incidence of cardiovascular disease is rising due to factors such as ageing, obesity, smoking and other cardiac ailments. Each year cardiovascular diseases cause... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3115 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3115 Wed, 27 May 2009 11:00:00 +0000 NAPA, California, May 15 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3056 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3056 Fri, 15 May 2009 21:30:00 +0000 CAPE TOWN, South Africa, May 11 /PRNewswire/ -- Africa's healthcare markets are starting to feel the effects of the global economic slowdown. Pressures from the global environment have led to rising... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3032 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3032 Mon, 11 May 2009 09:00:00 +0000 PHILADELPHIA and DUBLIN, April 30 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company, announces results for the three months to March 31, 2009. ... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2977 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2977 Thu, 30 Apr 2009 12:00:00 +0000 MCKINNEY, Texas, April 24 /PRNewswire/ -- Contact: Davida Walls of TORCHMARK CORPORATION, +1-972-569-3775 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2944 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2944 Fri, 24 Apr 2009 12:45:00 +0000 CHARENTON-LE-PONT, France, April 23 /PRNewswire/ -- Essilor International, the world leader in ophthalmic optics, today announced consolidated revenue of EUR840.4 million for the three months ended... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2934 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2934 Thu, 23 Apr 2009 06:25:00 +0000 MCKINNEY, Texas, April 22 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) reported today that for the quarter ended March 31, 2009, net income was US$.91 per share (after a charge of US$.49 per... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2931 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2931 Wed, 22 Apr 2009 21:01:00 +0000 DUBLIN, Ireland, April 20 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, will announce first quarter 2009 earnings on Thursday April 30, 2009. http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2913 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2913 Mon, 20 Apr 2009 17:41:00 +0000 PARIS, March 25 /PRNewswire/ -- Hello, The investor meeting relating to the 2008 earnings and 2009 outlook has been webcasted. The presentation is available in English from the following link: http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2781 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2781 Wed, 25 Mar 2009 17:43:00 +0000 BRITISH COLUMBIA, Canada, March 3 /PRNewswire/ -- InNexus Biotechnology Inc. (Toronto Stock Exchange: IXS.V), a drug development company commercializing the next generation of monoclonal antibodies... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2661 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2661 Tue, 03 Mar 2009 21:46:00 +0000 MCKINNEY, Texas, February 19 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) announced today that its Chief Executive Officer, Mark McAndrew, and Chief Financial Officer, Gary Coleman, will... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2582 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2582 Thu, 19 Feb 2009 18:40:00 +0000 LONDON, February 17 /PRNewswire/ -- The Chemicals Group at Frost & Sullivan is pleased to announce its 2009 Quarterly Analyst Briefing Presentation on Medical Trends Impacting the Chemicals and... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2559 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2559 Tue, 17 Feb 2009 10:50:00 +0000 LONDON, February 16 /PRNewswire/ -- The Healthcare Group at Frost & Sullivan is pleased to announce its 2009 Quarterly Analyst Briefing Presentation on the European Cardiac Rhythm Management... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2555 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2555 Mon, 16 Feb 2009 11:37:00 +0000 SAN FRANCISCO, February 12 /PRNewswire/ -- Coverity, Inc. announces the following TechOnline Webinar: Overview: http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2546 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2546 Thu, 12 Feb 2009 14:00:00 +0000 PHILADELPHIA and DUBLIN, Ireland, February 9 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, will announce full year 2008 earnings on Thursday 19... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2530 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2530 Mon, 09 Feb 2009 12:00:00 +0000 MCKINNEY, Texas, February 2 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) will release Fourth Quarter 2008 earnings after the market closes on Wednesday, February 4, 2009. In conjunction with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2507 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2507 Mon, 02 Feb 2009 12:45:00 +0000 MUMBAI, India, January 30 /PRNewswire/ -- Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) reported continuing growth for the third quarter ending... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2500 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2500 Fri, 30 Jan 2009 16:58:00 +0000 SAN DIEGO, January 30 /PRNewswire/ -- Gen-Probe Incorporated (Nasdaq: GPRO), a pioneer and leader in nucleic acid diagnostics for human disease, announced today that it has offered to acquire all the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2497 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2497 Fri, 30 Jan 2009 07:47:00 +0000 CHARENTON-LE-PONT, France, January 29 /PRNewswire/ -- Essilor International, the world leader in ophthalmic optics, today announced consolidated revenue of EUR3,074.5 million for the year... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2493 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2493 Thu, 29 Jan 2009 07:03:00 +0000 REHOVOT, Israel; JERSEY CITY, New Jersey; PHILADELPHIA, December 22 /PRNewswire/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG), a leading developer of microRNA-based molecular diagnostics, announced today... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2341 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2341 Mon, 22 Dec 2008 13:00:00 +0000 REHOVOT, Israel and JERSEY CITY, New Jersey, December 5 /PRNewswire/ -- Rosetta Genomics, Ltd. (NASDAQ: ROSG), an innovative molecular diagnostic company leveraging microRNAs as biomarkers, reported... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2259 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2259 Fri, 05 Dec 2008 12:30:00 +0000 MONTR http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2246 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2246 Wed, 03 Dec 2008 22:52:00 +0000 REHOVOT, Israel and JERSEY CITY, New Jersey, December 2 /PRNewswire/ -- In the news release, "Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results" issued on 26... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2234 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2234 Tue, 02 Dec 2008 13:30:00 +0000 REHOVOT, Israel and JERSEY CITY, New Jersey, November 26 /PRNewswire/ -- Rosetta Genomics (Nasdaq: ROSG), today announced it will release third quarter financial results on December 5, 2008, before... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2206 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2206 Wed, 26 Nov 2008 21:30:00 +0000 NAPA, California, November 14 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2135 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2135 Fri, 14 Nov 2008 21:30:00 +0000 LONDON, November 11 /PRNewswire/ -- Unilever is holding a two day Investor Seminar starting today, at Port Sunlight in the UK. Presentations will be webcast and available on Unilever's... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2101 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2101 Tue, 11 Nov 2008 13:12:00 +0000 SYDNEY, November 10 /PRNewswire/ -- iSOFT, an IBA Health Group Limited (ASX: IBA) company, today announced the global launch of LORENZO, the next generation software solution for healthcare... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2094 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2094 Mon, 10 Nov 2008 23:00:00 +0000 LONDON, November 10 /PRNewswire/ -- In these uncertain economic times, pharmaceutical organisations are dramatically re-evaluating their business models. The need for highly competitive cost... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2083 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2083 Mon, 10 Nov 2008 11:00:00 +0000 SAN MATEO, California, October 29 /PRNewswire/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2019 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2019 Wed, 29 Oct 2008 20:29:00 +0000 PHILADELPHIA, Pennysylvania and DUBLIN, Ireland, October 29 /PRNewswire/ -- Shire plc (LSE: SHP)(NASDAQ: SHPGY) the global specialty biopharmaceutical company announces results for the three months... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2011 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2011 Wed, 29 Oct 2008 12:42:00 +0000 CHARENTON-LE-PONT, France, October 23 /PRNewswire/ -- Essilor International, the world leader in ophthalmic optics, today announced its consolidated revenue for the nine months ended September 30,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1968 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1968 Thu, 23 Oct 2008 06:28:00 +0000 MCKINNEY, Texas, October 20 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) will release Third Quarter 2008 earnings after the market closes on Wednesday, October 22, 2008. In conjunction with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1936 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1936 Mon, 20 Oct 2008 13:00:00 +0000 SAN DIEGO, September 3 /PRNewswire/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) today announced that the company will present corporate updates at a number of upcoming industry and financial... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1621 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1621 Wed, 03 Sep 2008 12:30:00 +0000 CHARENTON-LE-PONT, France, August 28 /PRNewswire/ -- The Board of Directors of Essilor International, the world leader in ophthalmic optics, has approved the financial statements for the six months... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1584 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1584 Thu, 28 Aug 2008 06:36:00 +0000 ROCKVILLE, Maryland, August 26 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) announced today favorable results from the second stage of the Phase I/IIa human clinical trial of its pandemic influenza... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1568 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1568 Tue, 26 Aug 2008 13:00:00 +0000 NYON, Switzerland, August 25 /PRNewswire/ -- Mymetics Corporation (OTC: MYMX), will be holding an important conference call on Wednesday August 27th 2008 at 1 PM New York Time to update all... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1558 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1558 Mon, 25 Aug 2008 11:51:00 +0000 REHOVOT, Israel and JERSEY CITY, New Jersey, August 19 /PRNewswire/ -- Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of microRNA-based diagnostic and therapeutic products, reported today... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1542 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1542 Tue, 19 Aug 2008 09:30:00 +0000 NAPA, California, August 14 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1535 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1535 Thu, 14 Aug 2008 21:15:00 +0000 AMSTERDAM, August 13 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today reported its results for the first half year of 2008. http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1511 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1511 Wed, 13 Aug 2008 11:38:00 +0000 AMSTERDAM, August 13 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today reported its results for the first half year of 2008. http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1528 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1528 Wed, 13 Aug 2008 11:38:00 +0000 AMSTERDAM, The Netherlands, August 5 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that it will release its financial... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1483 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1483 Tue, 05 Aug 2008 06:00:00 +0000 COPENHAGEN, July 31 /PRNewswire/ -- Genmab A/S (OMX: GEN) and GlaxoSmithKline (LSE and NYSE: GSK) announced today positive top-line results from an interim analysis of the Phase III pivotal study... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1475 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1475 Thu, 31 Jul 2008 17:17:00 +0000 LONDON, July 24 /PRNewswire/ -- Key Highlights Misys plc (FTSE: MSY.L) delivers results ahead of expectations and is now raising targets for the next phase of the turnaround. Misys generated... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1442 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1442 Thu, 24 Jul 2008 07:00:00 +0000 BASINGSTOKE, England and PHILADELPHIA, July 4 /PRNewswire/ -- Shire Limited (LSE:SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, will announce second quarter 2008 earnings on... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1350 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1350 Fri, 04 Jul 2008 12:00:00 +0000 BASINGSTOKE, England and CAMBRIDGE, Massachusetts, July 3 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1338 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1338 Thu, 03 Jul 2008 08:30:00 +0000 MOUNTAIN VIEW, California, June 20 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that its corporate presentation will be webcast live during the Piper Jaffray... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1255 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1255 Fri, 20 Jun 2008 00:17:00 +0000 SAN DIEGO, June 3 /PRNewswire/ -- Gen-Probe Incorporated (Nasdaq: GPRO), a pioneer and leader in nucleic acid diagnostics for human disease, announced today that it has launched a conditional tender... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1139 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1139 Tue, 03 Jun 2008 13:22:00 +0000 EDMONTON, Canada, June 3 /PRNewswire/ -- Isotechnika Inc. will hold a conference call to discuss final Phase 2b PROMISE kidney transplant data for the Company's lead immunosuppressive... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1138 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1138 Tue, 03 Jun 2008 12:00:00 +0000 COPENHAGEN, May 28 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today results for the three month period ended March 31, 2008. During this period, Genmab reported the following results: ... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1084 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1084 Wed, 28 May 2008 19:20:00 +0000 REHOVOT, Israel and NORTH BRUNSWICK, New Jersey, May 21 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1051 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1051 Wed, 21 May 2008 13:30:00 +0000 REHOVOT, Israel and JERSEY CITY, New Jersey, May 14 /PRNewswire/ -- Rosetta Genomics (Nasdaq: ROSG), today announced it will release first quarter financial results on May 21, 2008, before the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/992 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/992 Wed, 14 May 2008 13:30:00 +0000 ST. DAVID'S, Bermuda, May 9 /PRNewswire/ -- Warner Chilcott Limited (Nasdaq: WCRX) today announced its results for the quarter ended March 31, 2008. Revenue in the quarter ended March 31,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/957 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/957 Fri, 09 May 2008 12:00:00 +0000 CALGARY, Canada, May 5 /PRNewswire/ -- Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that its 2008 Annual and Special Meeting of the Shareholders will be held on Wednesday, May 7,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/917 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/917 Mon, 05 May 2008 12:30:00 +0000 PRINCETON, New Jersey and MILAN, Italy, April 25 /PRNewswire/ -- Pharmasset, Inc. (Nasdaq: VRUS) announces the results of a 4-week Phase 1 clinical trial evaluating two oral dose levels of R7128 in... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/870 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/870 Fri, 25 Apr 2008 16:30:00 +0000 PRINCETON, New Jersey and MILAN, Italy, April 24 /PRNewswire/ -- -- Two 4-week cohorts will be enrolled to evaluate R7128 1500mg BID in HCV genotypes 2 and 3 prior non-responders and R7128 1000mg BID... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/858 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/858 Thu, 24 Apr 2008 14:16:00 +0000 COPENHAGEN, April 22 /PRNewswire/ -- TopoTarget A/S (OMX: TOPO) today announced that the company has successfully gained full control of belinostat so that global rights are now wholly owned by the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/831 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/831 Tue, 22 Apr 2008 09:42:00 +0000 MCKINNEY, Texas, April 16 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) reported today that for the quarter ended March 31, 2008, net income was US$1.29 per share compared with US$1.37 per share... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/809 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/809 Wed, 16 Apr 2008 21:00:00 +0000 COPENHAGEN, Denmark, March 31 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today results for the financial year ended December 31, 2007. Revenues of DKK 530 million (approximately USD 104... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/648 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/648 Mon, 31 Mar 2008 22:18:00 +0000